Deakin University
Browse

File(s) under permanent embargo

Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer

journal contribution
posted on 2020-11-01, 00:00 authored by Y Kanjanapan, S W Lok, P Gibbs, R De Boer, B Yeo, S Greenberg, F Barnett, L Knott, G Richardson, R Wong, M Nottage, Ian CollinsIan Collins, J Torres, J Lombard, J Johns, M Harold, L Malik
Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer

History

Journal

Breast cancer research and treatment

Volume

184

Issue

1

Pagination

87 - 95

Publisher

Springer

Location

Cham, Switzerland

Publisher DOI

ISSN

0167-6806

eISSN

1573-7217

Language

English

Author URL

Publication classification

C1 Refereed article in a scholarly journal

Usage metrics

    Research Publications

    Categories

    No categories selected

    Keywords

    Science & TechnologyLife Sciences & BiomedicineOncologyTrastuzumabPertuzumabMetastatic breast cancerDe novoNERVOUS-SYSTEM METASTASESADJUVANT TRASTUZUMABDE-NOVOCLINICAL-OUTCOMESBRAIN METASTASESCHEMOTHERAPYDOCETAXELRECURRENTSURVIVAL

    Licence

    All Rights Reserved

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC